AFFLUENT MEDICAL press release.
Affluent Medical completes its Management Committee in order to strengthen its development.
Affluent Medical, a French MedTech specializing in the international development and industrialization of innovative clinical-stage medical prostheses to treat cardiac mitral valve pathology and urinary incontinence, today announces the appointments of Christophe de Vregille as Chief Financial Officer and Benjamin Renault as Development Director. Christophe de Vregille and Benjamin Renault complete the management team in place to support the execution of the development plan and address the next steps leading to the commercialization of Affluent Medical’s three cutting-edge medical devices which have the potential to change the lives of patients with structural heart diseases and urological dysfunctions.